M|A|R|K|E|T
The import tax anomalies faced by MD manufacturers, are ‘tariff barriers’ erected against domestic companies UK-based Smith and Nephew group, a global leader in orthopaedic segment recently announced the acquisition of Sushrut-Adler, a home grown medical devices (MD) company catering to the trauma segment. Ajay Pitre, Managing Director, Sushrut-Adler group shares his thoughts on the challenges facing the Indian medical device industry in an interview with Shalini Gupta
at a faster pace to meet what could today be considered latent or unmet needs. However, this can happen only when the challenges of
INTERVIEW
How do you see Sushrut’s acquisition by Smith and Nephew? This is a unique agreement for the Indian orthopaedic industry wherein two companies with complementary businesses– Sushrut-Adler with its leadership position in trauma and Smith & Nephew’ with an established position in the Indian orthopaedic reconstruction and sports medicine market have come together to build a sustainable Indian business, as well as develop mid-tier trauma offerings for other emerging regions. From a purely Sushrut-Adler perspective, it gives us access to the broader global network and resources of Smith & Nephew. The entire management team, including myself, will become part of Smith & Nephew once the agreement is complete. Even as medical device imports continue to account for 60-70 per cent of the market, several innovative players such as Perfint, Trivitron and Forus have made a dent. How do you see the Indian medtech landscape? The acceptance of medical devices in India is driven by a growing awareness in both the medical community and patients who want to recover fast and get back to work. There is a strong likelihood of demand for more effective medical technology growing June 16-30, 2013
RS
Ready-to-Sterilize Components
Ready-to-Sterilize Packaging and Syringe Components
Low in bioburden and particulate
Pharmaceutical manufacturers around the world choose Westar ready-to-sterilize components for packaging their injectable drugs. Westar components can help streamline your filling and packaging operation and may help reduce your documentation requirements for regulatory filings. With West, you have a partner by your side from discovery to the patient.
Can be introduced directly into a steam autoclave Help streamline manufacturing processes Contact West today. +91 40 4940 1111 Literature.AsiaPacific@westpharma.com www.westpharma.com West and the diamond logo, Westar® and By your side for a healthier world™ are trademarks or registered trademarks of West Pharmaceutical Services, Inc., in the United States and other jurisdictions. Copyright ©2013 West Pharmaceutical Services, Inc. #7598
www.expresspharmaonline.com
EXPRESS PHARMA
17